Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000308751, described as a "novel transcript, antisense to TMEM55A," is annotated in Ensembl as a long non-coding RNA (lncRNA). This transcript is generated from the opposite strand of the TMEM55A (PIP4P2) locus, but there is no current evidence that it codes for a protein or serves as a direct therapeutic/functional target. It may play a regulatory role at the RNA level, but no specific biological functions, disease involvement, or drugs are associated with it at this time[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to TMEM55A.